Literature DB >> 2861306

Gastroenteropancreatic endocrine tumors.

C Weil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2861306     DOI： 10.1007/bf01731493

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  149 in total

1.  Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas.

Authors:  M P Dubois
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  THE ZOLLINGER-ELLISON SYNDROME: RE-APPRAISAL AND EVALUATION OF 260 REGISTERED CASES.

Authors:  E H ELLISON; S D WILSON
Journal:  Ann Surg       Date:  1964-09       Impact factor: 12.969

3.  Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis; a clinical and pathologic syndrome.

Authors:  A THORSON; G BIORCK; G BJORKMAN; J WALDENSTROM
Journal:  Am Heart J       Date:  1954-06       Impact factor: 4.749

4.  Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine.

Authors:  V ERSPAMER; B ASERO
Journal:  Nature       Date:  1952-05-10       Impact factor: 49.962

5.  Effects of somatostatin on insulin and glucagon in patients with insulinoma.

Authors:  F Fallucca; C Mirabella; G Tamburrano; S Gambardella; G Aufieri; F Barbetti; D Andreani
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

6.  Inhibitory effect of somatostatin on human pancreatic polypeptide secretion.

Authors:  J Marco; J A Hedo; M L Villanueva
Journal:  Life Sci       Date:  1977-09-15       Impact factor: 5.037

Review 7.  Carcinoid syndrome.

Authors:  M D Tilson
Journal:  Surg Clin North Am       Date:  1974-04       Impact factor: 2.741

Review 8.  Brain peptides (first of two parts).

Authors:  D T Krieger; J B Martin
Journal:  N Engl J Med       Date:  1981-04-09       Impact factor: 91.245

9.  Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue.

Authors:  R G Long; A J Barnes; T E Adrian; C N Mallinson; M R Brown; W Vale; J E Rivier; N D Christofides; S R Bloom
Journal:  Lancet       Date:  1979-10-13       Impact factor: 79.321

10.  Pancreatic somatostatinoma. Clinical features and physiological implications.

Authors:  L I Larsson; M A Hirsch; J J Holst; S Ingemansson; C Kühl; S L Jensen; G Lundqvist; J F Rehfeld; T W Schwartz
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321
View more
  2 in total

1.  Use of somatostatin analog in management of carcinoid syndrome.

Authors:  A Vinik; A R Moattari
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

Review 2.  Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.

Authors:  Thorvardur R Halfdanarson; Joseph Rubin; Michael B Farnell; Clive S Grant; Gloria M Petersen
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.